Skip to content

EVgo, Inc. EVGO Concentration Risk %

Concentration Risk % at other companies

Identive logo
IdentiveINVE
10.3%+7.7pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
RF Industries logo
RF IndustriesRFIL
100%0.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp

Segments

By geography

See full
CALIFORNIA55.1%+9.3%

Other financials

Income statement

See full
Revenue$109.5M+45.5%
Gross profit$13.0M+39.0%
Operating income-$36.3M-8.8%
Net income-$16.4M-44.5%
EPS (diluted)-$0.12-33.3%

Balance sheet

See full
Cash & equivalents$150.0M-12.1%
Total debt$322.5M+91.3%
Total equity$38.7M+205%
Total assets$920.3M+7.5%

Cash flow

See full
Operating cash flow-$35.4M-245%
CapEx$30.6M+104%
Free cash flow-$65.9M-161%

Valuation

See full
Market cap$269.42M-50.1%
Enterprise value$441.9M-22.9%
P/S0.6×-1.1×

Profitability

See full
Gross margin20.2%+8.7pp
Operating margin-27.2%-8.2pp
Net margin-11.1%-2.7pp
FCF margin-39.5%+9.1pp

Returns & leverage

See full
Return on equity-93.7%
Debt / equity8.3×
Current ratio2.1×-0.2×